GPCR News
Archived Headlines
- Nearly 80% of the year’s large IPOs are above issue, a positive signal for the fall IPO market 08/16/23
- US IPO Week Ahead: SharkNinja is the big fish in a week with small deals 07/28/23
- Biotechs Apogee and Sagimet slated to kick off the July IPO market 07/11/23
- Updated: Renaissance Capital's 1Q 2023 US IPO Market Review 04/03/23
- Renaissance Capital’s February IPO Market Update 03/01/23
See more
Here's what the top-performing IPOs of 2023 tell us about 2024
Get ready for a bevy of biotech IPOs. The 30 IPOs that raised $100 million or more in 2023 currently average a strong 25% return from offer, thanks to solid first day gains (+14%) that have built in the aftermarket (+9%). ...read more
CAR T cancer biotech CARGO Therapeutics targets a $300 million IPO, as it seeks to overcome weak trading from recent biotech listings
Another large biotech IPO has joined the calendar, seeking to buck the trend of mostly negative returns from recent listings in the industry. CARGO Therapeutics (CRGX) launched on Monday, planning to raise $300 million in what would be the...read more
Pessimism over Fed policy and geopolitical tensions topple year's large IPOs; here are the deals that have weathered the recent turmoil
After a strong rally through July, markets have treaded water for the past three months as investors grow pessimistic about the possibility of near-term rate cuts, against a backdrop of political gridlock in the US and a new war abroad. The year's sizable IPOs...read more
Large IPOs line up despite latest challenges
Despite geopolitical turmoil and a major flop from Birkenstock (BIRK) rocking the IPO market last week, a handful of large issuers are lining up to go public. Two sizable IPOs launched on Monday, joined by two notable initial filings. ...read more